Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926236-00-000036
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
28
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 1999 FORM 10-K 10-K 200017
2 EX-3.1 15675
3 EX-3.2 2019
4 EX-3.3 12757
5 EX-4.2 142220
6 EX-10.3 34440
7 EX-10.4 108862
8 EX-10.5 10407
9 EX-10.6 4609
10 EX-10.7 6277
11 EX-10.8 5477
12 EX-10.9 28650
13 EX-10.10 17734
14 EX-10.11 17769
15 EX-10.12 85251
16 EX-10.13 4958
17 EX-10.14 37335
18 EX-10.15 1245
19 EX-10.16 1217
20 EX-10.21 2915
21 EX-10.41 18417
22 EX-10.78 43748
23 EX-10.79 3048
24 EX-10.80 53292
25 EX-10.81 53290
26 EX-21.1 768
27 EX-23.1 1303
28 EX-27.1 2266
  Complete submission text file 0000926236-00-000036.txt   919215
Mailing Address PO BOX 168128 IRVING TX 75016-8128
Business Address 2001 WALNUT HILL LANE IRVING TX 75038 972-518-1300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10862 | Film No.: 585897
SIC: 2834 Pharmaceutical Preparations